Interactions between impulsivity and MDPV self-administration in rats.
Autorzy:
Abbott MS; Department of Pharmacology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. Seaman RW Jr; Department of Pharmacology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.; South Texas Veterans Health Care System, San Antonio, Texas, USA. DoyleMR; Department of Pharmacology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.; South Texas Veterans Health Care System, San Antonio, Texas, USA. Maguire DR; Department of Pharmacology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. Rice KC; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, NIDA and NIAAA, Bethesda, Maryland, USA. Collins GT; Department of Pharmacology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.; South Texas Veterans Health Care System, San Antonio, Texas, USA.
MDPV self-administration in female rats: influence of reinforcement history.
Autorzy:
DoyleMR; Department of Pharmacology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr - MC 7764, San Antonio, TX, 78229, USA.; South Texas Veterans Health Care System, San Antonio, TX, USA. Sulima A; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA. Rice KC; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, Intramural Research Program, National Institute on Drug Abuse and the National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA. Collins GT; Department of Pharmacology, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr - MC 7764, San Antonio, TX, 78229, USA. .; South Texas Veterans Health Care System, San Antonio, TX, USA. .
Pokaż więcej
Źródło:
Psychopharmacology [Psychopharmacology (Berl)] 2021 Mar; Vol. 238 (3), pp. 735-744. Date of Electronic Publication: 2020 Nov 24.
Interactions between reinforcement history and drug-primed reinstatement: Studies with MDPV and mixtures of MDPV and caffeine.
Autorzy:
DoyleMR; Department of Pharmacology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.; Research Service, South Texas Veterans Health Care System, San Antonio, Texas, USA. Sulima A; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, NIDA and NIAAA, Bethesda, Maryland, USA. Rice KC; Drug Design and Synthesis Section, Molecular Targets and Medications Discovery Branch, NIDA and NIAAA, Bethesda, Maryland, USA. Collins GT; Department of Pharmacology, The University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA.; Research Service, South Texas Veterans Health Care System, San Antonio, Texas, USA.
Pokaż więcej
Źródło:
Addiction biology [Addict Biol] 2021 Mar; Vol. 26 (2), pp. e12904. Date of Electronic Publication: 2020 Apr 01.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
N-Methyl-d-aspartate receptor co-agonist availability affects behavioral and neurochemical responses to cocaine: insights into comorbid schizophrenia and substance abuse.
Autorzy:
Puhl MD; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.; Laboratory for Psychiatric and Molecular Neuroscience, McLean Hospital, Belmont, MA, USA. Desai RI; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.; Preclinical Pharmacology Laboratory, McLean Hospital, Belmont, MA, USA. Takagi S; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.; Laboratory for Psychiatric and Molecular Neuroscience, McLean Hospital, Belmont, MA, USA.; Department of Psychiatry and Behavioral Sciences, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan. Presti KT; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.; Laboratory for Psychiatric and Molecular Neuroscience, McLean Hospital, Belmont, MA, USA. DoyleMR; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.; Preclinical Pharmacology Laboratory, McLean Hospital, Belmont, MA, USA. Donahue RJ; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.; Behavioral Genetics Laboratory, McLean Hospital, Belmont, MA, USA. Landino SM; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.; Behavioral Genetics Laboratory, McLean Hospital, Belmont, MA, USA. Bergman J; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.; Preclinical Pharmacology Laboratory, McLean Hospital, Belmont, MA, USA. Carlezon WA Jr; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.; Behavioral Genetics Laboratory, McLean Hospital, Belmont, MA, USA. Coyle JT; Department of Psychiatry, Harvard Medical School, Boston, MA, USA.; Laboratory for Psychiatric and Molecular Neuroscience, McLean Hospital, Belmont, MA, USA.
Pokaż więcej
Źródło:
Addiction biology [Addict Biol] 2019 Jan; Vol. 24 (1), pp. 40-50. Date of Electronic Publication: 2017 Nov 23.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
Behavioral phenotyping and dopamine dynamics in mice with conditional deletion of the glutamate transporter GLT-1 in neurons: resistance to the acute locomotor effects of amphetamine.
Autorzy:
Fischer KD; Department of Neurology and the F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, 02115, USA. Houston ACW; Department of Neurology and the F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, 02115, USA.; Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA. Desai RI; Preclinical Pharmacology Program, McLean Hospital/Harvard Medical School, Belmont, MA, 02478, USA. DoyleMR; Preclinical Pharmacology Program, McLean Hospital/Harvard Medical School, Belmont, MA, 02478, USA. Bergman J; Preclinical Pharmacology Program, McLean Hospital/Harvard Medical School, Belmont, MA, 02478, USA. Mian M; Department of Neurology and the F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, 02115, USA. Mannix R; Division of Emergency Medicine, Boston Children's Hospital, Boston, MA, 02115, USA. Sulzer DL; Department of Neurology, Columbia University, New York, NY, 10032, USA. Choi SJ; Department of Neurology, Columbia University, New York, NY, 10032, USA. Mosharov EV; Department of Neurology, Columbia University, New York, NY, 10032, USA. Hodgson NW; Department of Neurology and the F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, 02115, USA. Bechtholt A; National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, 20892, USA. Miczek KA; Departments of Psychiatry, Pharmacology, and Neuroscience, Tufts University, Boston, MA, 02111, USA. Rosenberg PA; Department of Neurology and the F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, 02115, USA. .; Program in Neuroscience, Harvard Medical School, Boston, MA, 02115, USA. .
Pokaż więcej
Źródło:
Psychopharmacology [Psychopharmacology (Berl)] 2018 May; Vol. 235 (5), pp. 1371-1387. Date of Electronic Publication: 2018 Feb 22.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
A novel p.Gly187Arg TP53 variant appears to result in Li-Fraumeni syndrome.
Autorzy:
DoyleMR; a Mercer University School of Medicine , Savannah , Georgia , USA. Johnston JM; b School of Medicine , Renown Children's Hospital, University of Nevada, Reno , USA.
Pokaż więcej
Źródło:
Pediatric hematology and oncology [Pediatr Hematol Oncol] 2018 Apr; Vol. 35 (3), pp. 203-207. Date of Electronic Publication: 2018 Sep 21.
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
